Delivering quality therapy since 1901

Announcements

 

 

Extraordinary Announcement1037<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-08-16T22:00:00Z8/17/2018 3:36:04 PMhttp://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Richter Group Report - 6 months to June 2018 1863<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-08-01T22:00:00Z8/2/2018 6:47:58 AM3417http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Composition of share capital and voting rights 1859<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-07-31T22:00:00Z8/1/2018 2:45:42 PM49http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
European Commission decision adopted CHMP opinion on the Esmya® referral1854<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.00000000000<strong>​</strong><span lang="EN-US"><strong>Gedeon Richter Plc. </strong></span><span lang="EN-GB"><strong>(“Richter”) announces that the</strong></span><span lang="EN-GB"><strong> European Commission (EC) implemented a decision concerning the marketing authorisations of Esmya® 5 mg. This decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on 1 June 2018 and is applicable for all Member States in the European Economic Area.</strong></span>2018-07-29T22:00:00Z7/30/2018 1:55:50 PM182http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Richter acquires all Bemfola® rights in respect of US1851<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.00000000000<p>​Gedeon Richter Plc (&quot;Richter&quot;) today announced that it concluded a sale and purchase agreement with Fertility Biotech AG (&quot;Fertility Biotech&quot;), a Swiss corporation, in connection with the transfer of intellectual property rights, relevant studies, related data and documents of r-hFSH containing product, BEMFOLA<sup>® </sup>/ AFOLIA, for the use in the United States. &#160;</p>2018-07-09T22:00:00Z7/10/2018 8:05:09 AM351http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Composition of share capital and voting rights1847<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-07-01T22:00:00Z7/2/2018 12:40:07 PM131http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary Announcement1843<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-06-28T22:00:00Z6/29/2018 1:00:26 PM1816http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary Announcement1845<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-06-28T22:00:00Z6/29/2018 1:15:24 PM1769http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary Announcement1785<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-06-27T22:00:00Z6/28/2018 11:30:40 AM1762http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary Announcement1828<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2018.000000000002018-06-21T22:00:00Z6/22/2018 12:50:15 PM1084http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx